Full Text View
Tabular View
No Study Results Posted
Related Studies
Specimens From Normal Controls
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), April 2009
First Received: June 19, 2006   Last Updated: April 17, 2009   History of Changes
Sponsored by: National Cancer Institute (NCI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00341211
  Purpose

The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For some research questions, specimens are available from "case" subjects as part of ongoing protocols but are not available from normal "control" subjects (i.e., those without the infection or disease under study) to whom the case subjects can be compared. This protocol is to obtain routine specimens (usually peripheral venous blood, occasionally other body fluid such as saliva, urine, or tears) from healthy volunteers.


Condition
Viral Infections

Study Type: Observational
Official Title: Specimens From Normal Controls

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 40
Study Start Date: April 1996
Detailed Description:

The Viral Epidemiology Branch (VEB) of the National Cancer Institute (NCI) conducts research on viral infections and their associations with various diseases including AIDS and cancer. For some research questions, specimens are available from "case" subjects as part of ongoing protocols but are not available from normal "control" subjects (i.e., those without the infection or disease under study) to whom the case subjects can be compared. This protocol is to obtain routine specimens (usually peripheral venous blood, occasionally other body fluid such as saliva, urine, or tears) from healthy volunteers.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Subjects can be friends of VEB investigator or collaborator, hospital or office workers, repeat volunteer blood donors, etc.

EXCLUSION CRITERIA:

Must not be minors, prisoners, pregnant women or incapable of providing informed consent.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00341211

Contacts
Contact: James J. Goedert, M.D. (301) 435-4724 goedertj@mail.nih.gov

Locations
United States, Maryland
National Cancer Institute (NCI), 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

No publications provided

Study ID Numbers: 999996013, OH96-C-N013
Study First Received: June 19, 2006
Last Updated: April 17, 2009
ClinicalTrials.gov Identifier: NCT00341211     History of Changes
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
AIDS
Cancer
Epidemiology
Immunology
Virology

Study placed in the following topic categories:
Virus Diseases

Additional relevant MeSH terms:
Virus Diseases
Infection

ClinicalTrials.gov processed this record on September 11, 2009